enVVeno Medical Corporation NVNO
8.67
(0.42)
(4.62%)
as of 25 Sep
- Market cap
- $6.3M
- P/E
- 0.0×
Follow NVNO
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (58.53%) | (60.65%) | (56.21%) | (57.19%) |
+8 more TTM periods Free account |
|
| (53.09%) | (56.45%) | (52.26%) | (53.09%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(77.56%) | (80.55%) | (72.78%) | (75.27%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(21.79) | (22.61) | (26.45) | (30.03) | |
Free Cash Flow |
(14.62) | (14.79) | (15.58) | (17.25) | |
Capital Expenditures |
— | — | (0.01) | (0.02) | |
| Other line items | |||||
Cash ROIC |
(34.69%) | (30.38%) | (28.13%) | (28.53%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.93 | 0.79 | 0.80 | 0.78 | |
Depreciation/Fixed assets |
5.00 | 30.69 | 9.59 | 6.02 | |
Capex/Depreciation |
0.00 | 0.00 | (0.02) | (0.04) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(21.79) | (22.61) | (26.43) | (30.00) | |
Capex per Share |
0.00 | 0.00 | (0.02) | (0.03) | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates